advertisement

---

Cioffi GA 26

Showing records 1 to 25 | Display all abstracts from Cioffi GA

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Dar S
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Hark LA
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
De Moraes CG
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Kresch YS; De Moraes CG
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Karani R
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Horowitz JD
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Khan S; Chen R
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Park L; Auran JD
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Blumberg D; Harizman N
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Gorroochurn P
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Krawitz B
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Stempel S
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Valenzuela IA
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Maruri SC
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Aliancy J
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Stidham EM; Banks AZ
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Tezel T
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Saaddine JB
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Horowitz J; Bearelly S
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Lambert BC; Pizzi LT
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Coleman DJ; Chang S
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Sapru S; Price S
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Cioffi GA
Journal of Glaucoma 2021; 30: 750-757

---

95197 Manhattan Vision Screening and Follow-up Study in Vulnerable Populations (NYC-SIGHT): Design and Methodology
Williams OA
Journal of Glaucoma 2021; 30: 388-394

---

94341 Patient Concerns Regarding Suspended Ophthalmic Care Due to COVID-19
Liebmann JM
Journal of Glaucoma 2021; 30: 750-757

---

• «
• 1
• 2
• »